Chester County News and Community Website
WASHINGTON, D.C. — A third and fourth COVID-19 vaccine dose offered substantial protection among adults with healthy immune systems who were eligible to receive them during Omicron variant evolution in …
CDC: Three Doses of COVID-19 Prove Effective Against the Omicron Variant Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test that detects chemical compounds in breath samples associated …
FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention recently announced two COVID-19 travel-related updates based on close-monitoring of the COVID-19 landscape in the United States and internationally.
CDC Mask Order Remains in Effect and CDC Realigns Travel Health Notice System Read More
WASHINGTON, D.C. — COVID-19 vaccination continues to help protect adults against severe illness with COVID-19, including hospitalizations and death, according to information released in the CDC’s most recent Morbidity and …
CDC: COVID-19 Vaccines Continue to Protect Against Hospitalization, Death Among Adults Read More
WASHINGTON, D.C. — U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra recently announced that the federal government has purchased 600,000 treatment courses of a new monoclonal antibody …
HHS Announces Purchase of 600,000 Treatment Courses of New Monoclonal Antibody That Works Against Omicron Read More
WASHINGTON, D.C. — On Friday, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for a new monoclonal antibody for the treatment of COVID-19 that retains activity against …
FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 Read More
RADNOR, PA — NRx Pharmaceuticals (NASDAQ: NRXP) states it has received scientific evidence from the Israel Institute for Biological Research (IIBR) that the BriLife® vaccine may produce effective levels of …
NRx Announces Publication of Initial Findings of BriLife Vaccine-produced Antibodies Against Omicron Variant Read More RADNOR, PA — NRx Pharmaceuticals (NASDAQ: NRXP has received a first safety report from a Southwestern hospital where physicians have administered ZYESAMI® (Aviptadil) to patients with COVID-19 respiratory failure.
NRx Receives Initial Report of Patient Safety and Survival from Right to Try Use of ZYESAMI During Omicron Surge Read More
WASHINGTON, D.C. — The following is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research:
FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant Read More
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) announced a recent update regarding its Investigational New Drug (IND) submission for IMM-BCP-01, a three-antibody cocktail, for the treatment of SARS-CoV-2 (COVID-19).
Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19 Read More